High levels of HA in the plasma of COVID-19 patients have been shown to directly induce endothelial barrier dysfunction in a ROCK- and CD44-dependent manner, indicating a role for HA in the vascular pathology of COVID-19 [86]. The gene discussed is CD44; the disease is COVID-19.